Literature DB >> 136142

Effect of antirheumatic drugs on neutral protease from human leucocyte granules.

D Kruze, K Fehr, H Menninger, A Böni.   

Abstract

The inhibitory effect of 38 antirheumatic and other agents on purified neutral protease from human polymorphonuclear leucocytes has been studied by determining the decrease in enzyme activity on Z-Ala-NPH as substrate. Analgesics, salicylates, cytostatic agents and steroids, as well as D-penicillamine, colchicine, allopurinol, chlorzoxazone and chlorpromazine, either had no effect on neutral protease or inhibited it only to a very small extent. Typical antirheumatic agents like gold and pyrazolone derivatives suppressed the activity of the enzyme at a concentration of 10(-5)M. The two sulphonated polysaccharides Arteparon and pentosan polysulphate (SP 54) were the most potent inhibitors of neutral protease (inhibition down to 10(-8)M). Increasing concentrations of various inorganic salts gradually suppressed the effect of some otherwise effective drugs on neutral protease. The drugs were completely ineffective at a salt concentration of 0.5 M. At physiological concentrations, however, this effect was insignificant. Inhibition of neutral protease may be one way in which some antirheumatic drugs exert a therapeutic effect in rheumatic diseases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 136142

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

Review 1.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

2.  Inhibition of human skin proteinases by chloroquine, dapsone and sulfapyridine.

Authors:  J E Fräki; V K Hopsu-Havu
Journal:  Arch Dermatol Res       Date:  1977-07-21       Impact factor: 3.017

3.  Cytochemical detection of proteases in synovial fluid of arthritic joints.

Authors:  M L Johannes; C Klessen
Journal:  Histochemistry       Date:  1981

4.  The inhibitory effects of antirheumatic drugs on the activity of human leukocyte elastase and cathepsin G.

Authors:  J Steinmeyer; D A Kalbhen
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

5.  Inhibition of leucocyte motility and prevention of immune-complex experimental colitis by hydroxychloroquine.

Authors:  J M Rhodes; J E McLaughlin; D J Brown; L A Nuttall; D P Jewell
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

Review 6.  Lysosomal elastase: effect on mechanical and biochemical properties of normal cartilage, inhibition by polysulfonated glycosaminoglycan, and binding to chondrocytes.

Authors:  H Menninger; H Burkhardt; W Röske; W Ehlebracht; B Hering; E Gurr; W Mohr; H D Mierau
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

7.  Drug induced impairment of polymorphonuclear cell bactericidal ability in rheumatoid arthritis.

Authors:  P Youinou; P Le Goff
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

Review 8.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 9.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

10.  Drug action on articular cartilage surface. An in vitro study using mouse femoral heads labeled with cationized ferritin.

Authors:  R Stanescu; J Peyron; V Stanescu
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.